-
1 . Academic Journal
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
- 저자
- by Van Cutsem, Eric; Peeters, Marc; Van den Evnde, Marc; André, Thierry; Borg, Christophe, et al.
- 소스
- In The Lancet Oncology May 2023 24(5):496-508